Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05289583

Acronym

DBT_dropout2

Enrollment

Registered

2022-03-21

Start date

2019-01-01

Completion date

2022-02-28

Last updated

2022-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Dropout, Psychotherapy

Brief summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Interventions

BEHAVIORALDialectical Behavior Therapy

DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion criteria

* inability to contract and consent, * other severe mental disorders (bipolar disorder, acute psychosis), * current alcohol, * illicit or not prescribed drug use, * simultaneous participation in other treatment studies, * pregnancy or breastfeeding, * an inability to negotiate a non-suicide agreement, * ongoing traumatic contact with the perpetrator, and * a Body Mass Index \< 16.5.

Design outcomes

Primary

Measure	Time frame	Description
Rate of Dropout	8-10 weeks	premature termination of treatment

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026